期刊文献+

对氧磷酸酯酶-1活性在2型糖尿病及血管病变中的改变 被引量:1

Study on the relationship between paraoxonase-1 and vascular complications in patients with type 2 DM
下载PDF
导出
摘要 目的:探讨PON-1活性在2型糖尿病(DM)中的改变及其在DM血管病变发生中的作用。方法:检测100例2型DM患者及40例正常对照的对氧磷酸酯酶-1(PON1)活性、总抗氧化能力(T-AOS)、氧化低密度脂蛋白(OX-LDL)、丙二醛(MDA)浓度变化,并按不同分组进行比较。血清PON-1活性用苯乙酸酯为底物,分光光度法测定,OX-LDL用ELISA法测定,MDA用硫带巴比妥酸法测定,T-AOS检测用分光光度法。结果:2型DM组PON-1活性比正常对照组显著降低(P<0.001),且与HDL减少无关,OX-LDL、MDA显著高于正常对照组(P<0.001,P<0.001),T-AOS显著低于正常对照(P<0.001)。合并血管病变的各组2型DM患者PON-1活性、T-AOS均低于无血管病变组,OX-LDL、MDA均高于无血管病变组。相关分析显示PON-1活性与T-AOS正相关(r=0.778,P<0.01),与OX-LDL(r=-0.643,P<0.01)呈负相关。PON-1活性影响因素经多元线性逐步回归分析,发现只有T-AOS、CHO、LDL、OX-LDL的回归系数P值<0.05。结论:2型DM患者PON-1活性下降,脂蛋白氧化易感性增加,血管易于损伤。PON-1活性降低是2型糖尿病大、微血管病变的危险因素。 Objective:To investigate the relationship between serum paraoxonase( PON-1) activity and vascular complications including microanginopathy and macroanginopathy in patients with type 2 diabetes mellitus (DM). Methods:Among one hundred patients with type 2 DM and forty normal controls, serum paraoxonase activity was assayed using phenyl acetate as a substrate;plasma oxidized low density lipoprotein (OX-LDL) was determined by ELISA; serum malondialdehyde (MDA) content and total antioxidant status(T-AOS) were also measured. Results:Serum PON1 activity was significantly lower in type 2 DM patients than that in controls(P〈0.001). Among patients with type 2 DM, PON1 activity was significantly decreased in subjects with microanginopathy, compared with those without complications. PON1 activity was positively correlated with T-AOS, negatively correlated with OX-LDL,age,duration, MDA, CHO, LDL. Conclusions:Decreased PON-1 activity is an independent risk factor of type 2 DM patients with vascular complications.
出处 《军医进修学院学报》 CAS 北大核心 2005年第4期285-287,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 糖尿病 血管疾病 磷酯酶类 脂蛋白类 DM vascular complication hospholipases lipoproteins
  • 相关文献

参考文献10

  • 1杜玮南,温进坤,韩梅.人血清对氧磷酶活性测定方法的建立及临床初步应用[J].河北医科大学学报,1999,20(3):134-136. 被引量:22
  • 2袁非综述.糖尿病系视网膜病变及其早期检测[J].国外医学:眼科学分册,2000,24:173-179.
  • 3Mecknenss B, Durrington PN, Mackness MI, et al. Paraoxonase and coronary heart disease[J]. Curr Opin Lipidol,1998, 119: 319-324.
  • 4Hedrick CL, Tiorpe SR. Glycation impairs high density lipoprotein function[J]. Diabetolgia, 2000, 43: 312-320.
  • 5Valabibl J, Avvril J, Li W, et al. High-density lipoprotein composition and paraoxonase activity in type 1 diabetes[J]. Clin Sci, 2001, 101: 659-670.
  • 6Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase(PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants[J]. Free Radic Biol Med, 1999, 26: 892-904.
  • 7Mertens A, Holvoet P. Oxidized LDL and HDL: antagonists in atherothrombosis[J]. FASEB J, 2001, 15: 2073-2084.
  • 8Marta T, Mariane S, Ferran GF, et al. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients[J]. Arterioscler Thromb Vasc Biol, 2000, 20: 2113-2119.
  • 9Aviram M, Rosenblat M, Billecke S, et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase[J]. Sci Med, 1999, 26: 892-904.
  • 10Hayek T, Fuhrman B, Vaya J, et al. The effect of meals rich in thermally stressed oliver and safflower oils on postprandial serum paraoxonase activity in patients with diabetes[J]. Arterioscler Thromb Vasc Biol,1997,23: 2744-2752.

共引文献21

同被引文献9

  • 1黄一宁,赵宇岚,李舜伟.同型半胱氨酸和MTHFR基因多态性与缺血性脑血管病的关系[J].中华医学杂志,2002,82(2):119-122. 被引量:54
  • 2Hoogeveen EK,Kostense PJ,Berks PJ,et al.Hyperhomocysteinemia is associated with an increase risk of cardiovascular disease,especially in non-insulin dependent diabetes mellitus:a population based study.Arterioscler Thromb Vasc Biol,1998,18:133-138.
  • 3Nygard O,Nordrehaud JE,Refsum H,et al.Plasma homocysteine levels and mortality in patients with coronary artery disease.N Engl J Med,1997,337:230-236.
  • 4Selhub J,Jacques PF,Wilson PWF,et al.Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.JAMA,1993,270:2693-2698.
  • 5Janel N,Robert K,Chabert C,et al.Mouse liver paraoxonase-1gene expressionis downregulated in hyperhomocysteinemia.Thromb Haemost,2004,92:221-222.
  • 6Mecknenss B,Durrington PN,Mackness MI,et al.Paraoxonase and coronary heart disease.Curr Opin Lipidol,1998,119:319-324.
  • 7Blundell G,Jones BG,Rose FA,et al.Homocysteine mediated endothelial cell toxicity and its amelioration.Atherosclerosis,1996,122:163-172.
  • 8Huang SR,Hsu Y,Lin HL,et al.Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers.J Nutr,2001,131:33-38.
  • 9Elkhairy L,Ueland PM,Refsum H,et al.Plasma total cysteine as a risk factor for vascular disease:the European Concerted Action Project.Circulation,2001,103:2544-2549.

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部